Skip to content
Nov 07 2014
Equity Strategies

Biotechnology Now Attractive; Purchased In Select Industries

  • Nov 7, 2014

This group offers low correlation, some defensive qualities, and a dose of volatility. Health Care is now the top rated broad sector and we are overweight this sector in Select Industries Portfolio.

tags

Biotechnology Health Care GS Scores Group Report

Login

For full access, please enter your credentials.

About The Author

Kristen Perleberg / Sr. Research Analyst & Co-Portfolio Manager

Kristen Perleberg

current issue

featured articles

recent tags
[ALL]

High Beta (19) Factors (89) Growth Vs. Value (39) Momentum (180) S&P 500 Capitalization Weighted (4) Consumer Discretionary (54) S&P 500 (345) P/E Ratios (31) Health Care (61) Donut Portfolio (6) 10-Month Moving Crossover Strategy (11) Asset Allocation (47) All Asset No Authority (13) Bear Market Rally (14) 50-Day Moving Average Crossover Signals (2) Breadth Thrust (6) NYSE Moving Balance Indicator (10) Smart Money (10) Insider Block Sales (3) Consumer Confidence - Present Situation (2)